Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.

@article{Altundag2004SalvageIC,
  title={Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.},
  author={Kadri Altundag and Sercan Aksoy and Ibrahim Halil Gullu and O Basak Altundag and Enis Ozyar and Şuayib Yalçin and Mustafa Cengiz and Fadil H. Akyol},
  journal={Medical oncology},
  year={2004},
  volume={21 3},
  pages={211-5}
}
This study evaluated the efficacy and toxicity of ifosfamide and doxorubicin chemotherapy regimen in Turkish patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) previously treated with platinum-based chemotherapy. Twenty-one patients with recurrent or metastatic NPC previously treated with platinum-based chemotherapy as adjuvant or palliative treatments who received ifosfamide 2500 mg/m(2) d 1-3, mesna 2500 mg/m(2) d 1-3, doxorubicin 60 mg/m(2) d 1, repeated every 21 d was… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Recurrent nasopharyngeal carcinoma: current management approaches.

American journal of clinical oncology • 2010
View 3 Excerpts
Highly Influenced

Treatment for metastatic nasopharyngeal carcinoma.

European annals of otorhinolaryngology, head and neck diseases • 2011

Similar Papers

Loading similar papers…